Epidemiological and clinical features of 308 hospitalized patients with novel 2009 influenza A (H1N1) virus infection in China during the first pandemic wave

Intervirology

Volumn 54, Issue 3, 2011, Pages 164-170

  Zhang, Guoliang ^a,b   Xia, Zhang ^b   Liu, Yingxia ^b   Li, Xiuhui ^c   Tan, Xinghua ^d   Tian, Yimei ^c   Liang, Lianchun ^c   Nie, Guang ^b   Zhou, Boping ^a,b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Shenzhen Third Hospital   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d Guangzhou Eighth Hospital   (China)

Author keywords

H1N1, clinical features; H1N1, epidemiology; Oseltamivir

Indexed keywords

ANTIVIRUS AGENT; OSELTAMIVIR; SIALIDASE INHIBITOR; ZANAMIVIR;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHINA; CLINICAL FEATURE; COUGHING; FEVER; HEADACHE; HOSPITAL PATIENT; HUMAN; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHINORRHEA; SORE THROAT; TRAVEL; TREATMENT RESPONSE; VIRUS DETECTION; VIRUS LOAD;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OSELTAMIVIR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; TREATMENT OUTCOME; YOUNG ADULT;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 78049398116     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319930     Document Type: Article

References (28)

1. Naffakh N, van der Werf S: April 2009: an outbreak of swine-origin influenza A (H1N1) virus with evidence for human-tohuman transmission. Microbes Infect 2009;11:725-728.
2. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstorm S, Garten RJ, Gubareva LV, Xu X, Bridge CB, Uyeki TM, Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team: Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Eng J Med 2009;360:2605-2615.
3. World Health Organization: Global alert and response, pandemic (H1N1) 2009, frequently asked questions: what is phase 6? Geneva, WHO, 2009. www.who.int/csr/disease/swineflu/frequently-asked-questions/levels-pandemic- alert/en/index.html (accessed August 30, 2010).
4. World Health Organization: Pandemic (H1N1) 2009. Update 74. Geneva, WHO, 2009. www.who.int/csr/don/2009-11-13/en/index.html (accessed August 30, 2010).
5. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burker DF, Fouchier RA, Pappas C, Alpuche-Aranda CM, López-Gatell H, Olivera H, López I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD Jr, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongis EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ: Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circu lating. Science 2009;325:197-201.
6. Trifonov V, Khiabanian H, Greenbaum B, Rabbadan R: The origin of the recent swine influenza A (H1N1) virus infecting humans. Euro Surveill 2009;14:19193.
7. Chen H, Wang Y, Liu W, Zhang J, Dong B, Fan X, de Jong MD, Farrar J, Riley S, Smith GJ, Guan Y: 1Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China. Emerg Infect Dis 2009;15:1849-1850.
8. Echevarría-Zuno S, Mejía-Aranguré JM, Mar-Obeso AJ, Grajales-Muniz C, Robles-Pérez E, González-León M, Ortega-Alvarez MC, Gonzalez-Bonilla C, Rascón-Pacheco RA, Borja-Aburto VH: Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009;374:2072-2079.
9. Castro-Jiménez MA, Castillo-Pabón JO, Rey-Benito GJ, Pulido-Domínguez PA, Barbosa-Ramírez J, Velandia-Rodriguez DA, Angulo-Martínez ES: Epidemiologic analysis of the laboratory-confirmed cases of influenza A (H1N1) v in Colombia. Euro Surveill 2009;14:19284.
10. Ciblak MA, Albayrak N, Odabas Y, Basak Altas A, Kanturvardar M, Hasoksuz M, Sucakli B, Korukluoglu G, Bal E, Ertek M, Badur S: Cases of influenza A (H1N1) v reported in Turkey, May-July 2009. Euro Surveill 2009;14:19304.
11. Boivin G, Hardy I, Tellier G, Maziade J: Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis 2000;31:1166-1169. (Pubitemid 32295445)
12. Navarro-Mari JM, Perez-Ruiz M, Cantudo-Munoz P, Petit-Gancedo C, Jimenez-Valera M, Rosa-Fraile M: Influenza-like illness criteria were poorly related to laboratory-confirmed influenza in a sentinel surveillance study. J Clin Epidemiol 2005;58:275-279. (Pubitemid 40249470)
13. Centers for Disease Control and Prevention protocol of real time RT-PCR for influenza A (H1N1). Atlanta, CDC, 2009.
14. Cao B, Li XW, Shu YL, Jiang N, Chen SJ, Xu XY, Wang C: Characteristics of 3 early cases of influenza A pandemic (H1N1) 2009 virus infection, People's Republic of China, 2009. Emerg Infect Dis 2009;15:1418-1422.
15. Crum-Cianflone NF, Blair PJ, Faix D, Arnold J, Echols S, Sherman SS, Tueller JE, Warkentien T, Sanguineti G, Bavaro M, Hale BR: Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States military beneficiaries. Clin Infec Dis 2009;49:1801-1810.
16. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, Sugerman DE, Druckenmiller JK, Ritger KA, Chugh R, Jasuja S, Deutscher M, Chen S, Walke JD, Duchin JS, Lett S, Soliva S, Wells EV, Swerdlow D, Uyeki TM, Fiore AE, Olsen SJ, Fry AM, Bridges CB, Finelli L: Pandemic Influenza A (H1N1) Virus Hospitalization Investigation Team. 2009. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Eng J Med 2009;361:1935-1944.
17. Komiya N, Gu Y, Kamiya H, Yahata Y, Matsui T, Yasui Y, Okabe N: Clinical features of cases of influenza A (H1N1) virus in Osaka prefecture, Japan, May 2009. Euro Surveill 2009;14:1-3.
18. Health Protection Agency, Health Protection Scotland, National Public Health Services for Wales, HPA Northern Ireland Swine influenza investigation teams: Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April-June 2009. Euro Surveil l 2009;14:19232.
19. Centers for Disease Control and Prevention: Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep 2009;58:467-470.
20. Gianella A, Walter A, Revollo R, Loayza R, Vargas J, Roca Y: Epidemiologic analysis of the inf luenza A (H1N1) voutbreak in Bolivia, May-August 2009. Euro Surveill 2009;14:19323.
21. Morens DM, Fauci AS: The 1918 influenza pandemic: insights for the 21st century. J Infect Dis 2007;195:1018-1028. (Pubitemid 46452108)
22. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser CA, Samuel MC, Rosenberg J, Talarico J, Hatch D, California Pandemic (H1N1) Working Group: Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA 2009;302:1896-1902.
23. Monto AS: The risk of seasonal and pandemic influenza: prospects for control. Clin Infect Dis 2009;48(suppl 1):20-25.
24. Finelli L, Fiore A, Dhara R, Brammer L, Shay DK, Kamimoto L, Fry A, Hageman J, Gorwitz R, Bresee J, Uyeki T: Influenz a-a ssociated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008;22:805-811.
25. Centers for Disease Control and Prevention (CDC): Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. Atlanta, CDC, 2009. www.cdc.gov/h1n1flu/recommendations.htm.
26. McGeer A, Green KA, Plevneshi A, Shigayeva A, Siddiqi N, Rabound J, Low DE; Toronto Invasive Bacterial Diseases Network: Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007;45:1568-1575. (Pubitemid 351411840)
27. Centers for Disease Control and Prevention: Oseltamivir resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxia-North Carolina, 2009. MMWR Morb Mortal Wkly Rep 2009;58:969-972.
28. Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin ME, Boivin G: Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N Engl J Med 2009;361:2296-2297.